| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
vß3,
vß5, and
vß61
Institut de Chimie Biologique, ER CNRS 079, Université d'Aix-Marseille I, 3 place Victor Hugo 13331 Marseille Cedex 3 [M. L., C. R., J. P., J. M.]; Institut de Biologie et Chimie des Protéines, UPR CNRS 412, 7 passage du Vercors, 69007 Lyon, France [J-C. L.]; and Department of Cell Biology, The Scripps Research Institute, La Jolla, California 92037 [R. T., V. Q.]
Using whole viable human colon carcinoma HT29 cells as immunogen, we produced a monoclonal antibody (mAb) termed 69-6-5. The antibody was functionally selected on its anti-cell-spreading activity. By immunoprecipitation of surface radiolabeled cell lysates from HT29-D4 cells (an HT29 cell clone), mAb 69-6-5 recognized a molecular complex resembling integrin heterodimers. Sequential immunodepletions with mAb to the integrin
v subunit demonstrated that this complex was composed of
v-containing integrins. Accordingly, mAb 69-6-5 reacted with integrin
vß3 immunopurified from melanoma cells and integrins
vß5 and
vß6 immunopurified from pancreatic carcinoma cells. In cell adhesion assays, the 69-6-5 mAb was able to inhibit strongly in a dose-dependent manner arginine-glycine-aspartic acid-mediated adhesion of HT29-D4 cells to vitronectin, fibronectin, or ProNectin F but not to laminin or collagen. Immunoprecipitations with ß chain-specific antisera indicated that these cells express integrins
vß5 (receptor for vitronectin) and
vß6 (receptor for fibronectin) but neither
vß1 nor
vß3.
In summary, these results indicated that mAb 69-6-5 reacts with several
v integrins and that it can effectively interfere with the adhesive functions of at least
vß5 and
vß6, which represent the major receptors on HT29-D4 cells responsible for their adhesion on vitronectin and fibronectin.
1 This work was supported by Institut National de la Santé et de la Recherche Médicale Grant CRE 920 205, the Fédération Nationale des Centres de Lutte Contre le Cancer, and the Association de Recherche sur le Cancer.
2 To whom requests for reprints should be addressed.
3 These two authors contributed equally to the completion of the biochemical part of this work.
Received 5/21/93. Accepted 2/18/94.
This article has been cited by other articles:
![]() |
M. Nejjari, V. Berthet, V. Rigot, S. Laforest, M.-F. Jacquier, N. G. Seidah, L. Remy, E. Bruyneel, J.-Y. Scoazec, J. Marvaldi, et al. Inhibition of Proprotein Convertases Enhances Cell Migration and Metastases Development of Human Colon Carcinoma Cells in a Rat Model Am. J. Pathol., June 1, 2004; 164(6): 1925 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Reinmuth, W. Liu, S. A. Ahmad, F. Fan, O. Stoeltzing, A. A. Parikh, C. D. Bucana, G. E. Gallick, M. A. Nickols, W. F. Westlin, et al. {alpha}v{beta}3 Integrin Antagonist S247 Decreases Colon Cancer Metastasis and Angiogenesis and Improves Survival in Mice Cancer Res., May 1, 2003; 63(9): 2079 - 2087. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, Z. Li, E.-K. Viklund, and S. Stromblad p21-activated kinase 4 interacts with integrin {alpha}v{beta}5 and regulates {alpha}v{beta}5-mediated cell migration J. Cell Biol., September 29, 2002; 158(7): 1287 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Soudais, S. Boutin, S. S. Hong, M. Chillon, O. Danos, J. M. Bergelson, P. Boulanger, and E. J. Kremer Canine Adenovirus Type 2 Attachment and Internalization: Coxsackievirus-Adenovirus Receptor, Alternative Receptors, and an RGD-Independent Pathway J. Virol., November 15, 2000; 74(22): 10639 - 10649. [Abstract] [Full Text] |
||||
![]() |
A. Erdreich-Epstein, H. Shimada, S. Groshen, M. Liu, L. S. Metelitsa, K. S. Kim, M. F. Stins, R. C. Seeger, and D. L. Durden Integrins {{alpha}}v{beta}3 and {{alpha}}v{beta}5 Are Expressed by Endothelium of High-Risk Neuroblastoma and Their Inhibition Is Associated with Increased Endogenous Ceramide Cancer Res., February 1, 2000; 60(3): 712 - 721. [Abstract] [Full Text] |
||||
![]() |
V Rigot, M Lehmann, F Andre, N Daemi, J Marvaldi, and J Luis Integrin ligation and PKC activation are required for migration of colon carcinoma cells J. Cell Sci., January 10, 1998; 111(20): 3119 - 3127. [Abstract] [PDF] |
||||
![]() |
S Colucci, G Giannelli, M Grano, R Faccio, V Quaranta, and A. Zallone Human osteoclast-like cells selectively recognize laminin isoforms, an event that induces migration and activates Ca2+ mediated signals J. Cell Sci., January 6, 1996; 109(6): 1527 - 1535. [Abstract] [PDF] |
||||
![]() |
S. Ryeom, J. Sparrow, and R. Silverstein CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium J. Cell Sci., January 2, 1996; 109(2): 387 - 395. [Abstract] [PDF] |
||||
![]() |
F Mitjans, D Sander, J Adan, A Sutter, J. Martinez, C. Jaggle, J. Moyano, H. Kreysch, J Piulats, and S. Goodman An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice J. Cell Sci., January 8, 1995; 108(8): 2825 - 2838. [Abstract] [PDF] |
||||
![]() |
V. Berthet, V. Rigot, S. Champion, J. Secchi, F. Fouchier, J. Marvaldi, and J. Luis Role of Endoproteolytic Processing in the Adhesive and Signaling Functions of alpha vbeta 5 Integrin J. Biol. Chem., October 20, 2000; 275(43): 33308 - 33313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |